Here's something new: our first-ever Post-Hoc Live happens tomorrow at noon ET
Watch @drewsnews.bsky.social, @maxbayer.bsky.social and @annajbrown.bsky.social talk pharma & tariffs — while live!
endpts.com/how-pharma-i...
Here's something new: our first-ever Post-Hoc Live happens tomorrow at noon ET
Watch @drewsnews.bsky.social, @maxbayer.bsky.social and @annajbrown.bsky.social talk pharma & tariffs — while live!
endpts.com/how-pharma-i...
Johnson & Johnson CEO Joaquin Duato subtly but assertively criticized President Donald Trump's plans for pharmaceutical tariffs, saying tax policy is a better way to onshore US drug manufacturing.
endpts.com/jj-ceo-chide...
While Trump has launched a 232 investigation to tax pharmaceuticals, he's simultaneously issued an executive order to lower US drug prices. See @zacharybrennan.bsky.social coverage on this at @endpts.com: endpts.com/trump-pledge...
Pharma tariffs are likely to leave little room to hide for companies as the 232 investigation hits all the major parts of the supply chain: endpts.com/trumps-pharm...
Yesterday I wrote a piece for @endpts.com on what Trump's potential tariff rollout could look like for pharmaceuticals: endpts.com/pharma-tarif...
But CDMOs seem more concerned with the current FDA staff cutbacks delaying inspections: endpts.com/cdmos-antici...
Former FDA Commissioner:
🚨 Breaking: Firings swept across the FDA, gutting leadership and whole offices, as some staff found out their jobs were cut when they showed up to work on Tuesday.
endpts.com/firings-swee...
Ahead of potential pharmaceutical tariffs next week, @maxbayer.bsky.social broke down what this could mean for the industry @endpts.com:
endpts.com/trump-pharma...
DOGE terminates lease on FDA pharma quality lab in St. Louis that employs about 70 scientists - unclear on their fate endpts.com/doge-shutter...
Endpoints weekly manufacturing newsletter's out today, leading with our story on Lilly's $27 billion manufacturing push in the US from @zacharybrennan.bsky.social
endpts.com/lilly-says-i...
We are too! DM me or find me on Signal at zacharybrennan.20
Some of the user fee-funded staff at FDA were reinstated on Monday, after being laid off about a week ago for dubious reasons. 183 of the 230 staffers initially let go were supported by the user fee program endpts.com/some-fda-med...
Amanda Pritchard quits as NHS England chief executive in shock move
Young scientists, doctors, and public health professionals who earned prestigious federal fellowships are getting the axe from Trump. Is this how to plan for the next pandemic?
“We owe them a debt of gratitude, not a pink slip,” former agency heads said.
www.nytimes.com/2025/02/18/u...
Pfizer CEO Bourla: “Do I think we can convince them to do something bold in vaccines with Kennedy in HHS? Probably not. But do I think that we can convince them to do something very bold for cancer or for cardiovascular diseases with Kennedy in HHS? Absolutely I do.”
endpts.com/pfizer-ceo-s...
The terms of the Executive Orders are extraordinarily vague and could prohibit Plaintiffs from engaging in any targeted effort to help a specific group of people facing unfair disadvantages. The Executive Orders equate banned "DEIA" with any equity-related work— potentially including work that is specifically authorized or required by civil rights laws-and explicitly prohibit references to "DEI and DEIA principles, under whatever name they may appear." Without any discernible standards or criteria of what is and what is not "dangerous, demeaning," "immoral," and "illegal" DEIA,' as understood by this Administration, the future of Plaintiffs' fiscal viability and programming are subject to the unfettered discretion of an Administration that has made clear its predisposition against any speech or action that advances equal opportunity for historically marginalized groups, including people of color, women, LGBTQ people, and/or people with disabilities. Such vague terms without sufficient standards or criteria deprive Plaintiffs of their due process rights under the Fifth Amendment. 9. In addition to violating Plaintiffs' free speech and due process rights, the Executive Orders have a clear discriminatory purpose in violation of equal protection: to malign the targeted communities; to undermine and dismantle a wide spectrum of policies, programs, and activities intended to help historically marginalized, underserved, and under-resourced groups; and to erase transgender people from public life.
REQUEST FOR RELIEF Plaintiffs respectfully request that the Court grant the following relief: A. A declaration pursuant to 28 U.S.C. § 2201 that Executive Order Nos. 14151, 14168, and 14173 and any implementing agency actions are unlawful, unconstitutional, and invalid. A permanent injunction enjoining Defendants, their officials, agents, employees, assigns, and all persons acting in concert or participating with them from implementing or enforcing Executive Order Nos. 14151, 14168, and 14173, including without limitation the promulgation of any rules or regulations, in any manner against Plaintiffs by way of contract, subcontract, purchase order, grant, or sub-grant. C. A permanent injunction mandating that Defendants permanently rescind all agency-wide directives implementing and effectuating Executive Order Nos. 14151, 14168, and 14173 against Plaintiffs that were issued prior to this injunction. D. A permanent injunction mandating that Defendants unwind, rescind, strike, modify, or otherwise rectify contracts, subcontracts, agreements, and/or any other such binding documents entered into with Plaintiffs, in which terms, clauses, or provisions have been inserted pursuant to or in furtherance of Executive Order Nos. 14151, 14168, and 14173.
BREAKING: Nonprofits sue over Trump's anti-diversity, anti-trans executive orders, alleging they violate the First Amendment & equal protection guarantees, are void for vagueness, exceed the president's authority, & violate the Administrative Procedure Act. storage.courtlistener.com/recap/gov.us...
Hello! Still in the process of moving over to Bluesky, for new friends: I write about biomanufacturing and supply chains over at @endpts.com -- feel free to reach out at abrown@endpointsnews.com for tips or just to say hi!
A taster of some manufacturing news today:
endpts.com/pfizers-manu...
We’ve seen this movie before.